Table 1.
Protumorigenic effects | References |
---|---|
(1) Inhibition of PPAR-γ genomic functions by MAPK | [108, 126–143] |
(2) PPAR-γ nongenomic functions (MAPK activation, MMP2, and VEGF production) | |
| |
Antitumorigenic effects | References |
| |
(1) PPAR-γ genomic effects | [109, 144–151] |
(2) Induction of PTEN expression | |
(3) Inhibition of p70S6K |